APA

Chambers M. S., Atack J. R., Carling R. W., Collinson N., Cook S. M., Dawson G. R., Ferris P., Hobbs S. C., O'connor D., Marshall G., Rycroft W. & Macleod A. M. (20050103). An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. : Journal of medicinal chemistry.

Chicago

Chambers Mark S, Atack John R, Carling Robert W, Collinson Neil, Cook Susan M, Dawson Gerard R, Ferris Pushpindar, Hobbs Sarah C, O'connor Desmond, Marshall George, Rycroft W and Macleod Angus M. 20050103. An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. : Journal of medicinal chemistry.

Harvard

Chambers M. S., Atack J. R., Carling R. W., Collinson N., Cook S. M., Dawson G. R., Ferris P., Hobbs S. C., O'connor D., Marshall G., Rycroft W. and Macleod A. M. (20050103). An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. : Journal of medicinal chemistry.

MLA

Chambers Mark S, Atack John R, Carling Robert W, Collinson Neil, Cook Susan M, Dawson Gerard R, Ferris Pushpindar, Hobbs Sarah C, O'connor Desmond, Marshall George, Rycroft W and Macleod Angus M. An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. : Journal of medicinal chemistry. 20050103.